Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Obesity and novel management of inflammatory bowel disease
Jee Hyun Kim, Chang‐Myung Oh, Jun Hwan Yoo
World Journal of Gastroenterology (2023) Vol. 29, Iss. 12, pp. 1779-1794
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Human umbilical cord/placenta mesenchymal stem cell conditioned medium attenuates intestinal fibrosis in vivo and in vitro
Yoon Jeong Choi, Woo Ram Kim, Duk Hwan Kim, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management
Wissam Ghusn, Edward V. Loftus, Amanda M. Johnson
Current Opinion in Gastroenterology (2024) Vol. 40, Iss. 4, pp. 268-275
Closed Access | Times Cited: 5
The obesity pandemic and its impact on non-communicable disease burden
Staffan Hildebrand, Alexander Pfeifer
Pflügers Archiv - European Journal of Physiology (2025)
Open Access
Global burden of colorectal cancer attributable to metabolic risks from 1990 to 2021, with projections of mortality to 2035
Mingming He, Ruru Gu, Xin Huang, et al.
International Journal of Colorectal Disease (2025) Vol. 40, Iss. 1
Open Access
Recomendaciones sobre el manejo de la obesidad grave en pacientes con enfermedad inflamatoria intestinal del Grupo Español de Trabajo en Enfermedad Inflamatoria Intestinal (GETECCU), Sociedad Española de Obesidad (SEEDO), Asociación Española de Cirugía (AEC) y Sociedad Española de Endoscopia Digestiva (SEED)
Eugeni Domènech, Andreea Ciudin, José M. Balibrea, et al.
Gastroenterología y Hepatología (2024) Vol. 47, Iss. 8, pp. 906-923
Open Access | Times Cited: 4
Electroacupuncture Reduces Inflammatory Bowel Disease in Obese Mice by Activating the Nrf2/HO-1 Signaling Pathways and Repairing the Intestinal Barrier
Yunhao Yang, Fang Pang, Min Zhou, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 435-452
Open Access | Times Cited: 3
Navigating the Gut-Cardiac Axis: Understanding Cardiovascular Complications in Inflammatory Bowel Disease
Tanya Sinha, Zukhruf Zain, Syed Faqeer Hussain Bokhari, et al.
Cureus (2024)
Open Access | Times Cited: 3
Ginsenoside Rg1 Alleviates Ulcerative Colitis in Obese Mice by Regulating the Gut Microbiota–Lipid Metabolism–Th1/Th2/Th17 Cells Axis
Youbao Zhong, Qiuping Xiao, Jiaqi Huang, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 50, pp. 20073-20091
Closed Access | Times Cited: 10
Adiponectin restores the obesity-induced impaired immunomodulatory function of mesenchymal stromal cells via glycolytic reprogramming
Duc‐Vinh Pham, Thi-Kem Nguyen, Bao-Loc Nguyen, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 273-291
Open Access | Times Cited: 7
The Role of the Gastroenterologist in Obesity Management: Now Is the Right Time for Our Involvement
Stephanie Gold, Asher Kornbluth
The American Journal of Gastroenterology (2024) Vol. 119, Iss. 6, pp. 1001-1006
Closed Access | Times Cited: 2
Adolescent gut microbiome imbalance and its association with immune response in inflammatory bowel diseases and obesity
Minjae Joo, Seungyoon Nam
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
The Relationship of Adherence to the Mediterranean Diet with Disease Activity and Quality of Life in Crohn’s Disease Patients
Athanasios Migdanis, Ioannis Migdanis, Nikoleta D. Gkogkou, et al.
Medicina (2024) Vol. 60, Iss. 7, pp. 1106-1106
Open Access | Times Cited: 1
GLP-1 Receptor Agonists Confer No Increased Rates of IBD Exacerbation Among Patients With IBD
Irving Levine, Shaina Sekhri, William Schreiber-Stainthorp, et al.
Inflammatory Bowel Diseases (2024)
Closed Access | Times Cited: 1
Micronutrient Deficiency and Muscular Status in Inflammatory Bowel Disease
Joonhee Han, Hyun Joo Song, Min‐Sook Kang, et al.
Nutrients (2024) Vol. 16, Iss. 21, pp. 3763-3763
Open Access | Times Cited: 1
Impact of Bariatric Surgery on Outcomes of Patients with Inflammatory Bowel Disease: a Nationwide Inpatient Sample Analysis, 2005–2018
I‐Chen Lin, Hsien Liu
Obesity Surgery (2023) Vol. 34, Iss. 2, pp. 479-486
Closed Access | Times Cited: 3
Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-associated fatty liver disease: usefulness of non-invasive steatosis predictive scores
Tiago Lima Capela, Vítor Macedo Silva, Marta Freitas, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Computed tomography-based body composition parameters can predict short-term prognosis in ulcerative colitis patients
Jun Lü, Hui Xu, Haiyun Shi, et al.
Insights into Imaging (2024) Vol. 15, Iss. 1
Open Access
Predictors of histologic remission in patients with biologic-naïve, moderate-to-severe ulcerative colitis treated with first-line biologic agents and small-molecule drugs: a single-center, retrospective cohort study
Ki Jae Jo, Kwang Woo Kim, Hyun Jung Lee, et al.
Intestinal Research (2024) Vol. 22, Iss. 4, pp. 453-463
Open Access
The Rising Epidemic of Obesity in Patients with Inflammatory Bowel Disease
Jellyana Peraza, Erin Abbott, Mark Shneyderman, et al.
Current Treatment Options in Gastroenterology (2024) Vol. 22, Iss. 3, pp. 134-144
Closed Access
Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD
Sara Sila, M Aloi, U Cucinotta, et al.
Inflammatory Bowel Diseases (2024)
Closed Access
Recommendations on the management of severe obesity in patients with inflammatory bowel disease of the Spanish Group on Crohn’s Disease and Ulcerative Colitis (GETECCU), Spanish Society of Obesity (SEEDO), Spanish Association of Surgery (AEC) and Spanish Society of Digestive Endoscopy (SEED)
Eugeni Domènech, Andreea Ciudin, José M. Balibrea, et al.
Gastroenterología y Hepatología (English Edition) (2024) Vol. 47, Iss. 8, pp. 906-923
Open Access
New Onset Inflammatory Bowel Disease Risk Following Bariatric Surgery: A Systematic Review and Meta-Analysis of Observational Studies
Wafa Ali Aldhaleei, Tarek Odah, Nader Bakheet, et al.
Gastroenterology Insights (2024) Vol. 15, Iss. 3, pp. 708-719
Open Access
Efficacy and Safety of Glp-1 Agonists on Metabolic Parameters in Non-diabetic Patients With Inflammatory Bowel Disease
Joëlle St‐Pierre, Jeremy Klein, Natalie K. Choi, et al.
Research Square (Research Square) (2024)
Open Access
Risk Factors for Gallstones in Crohn’s Disease: A Systematic Review and Meta-Analysis
Yan Gong, Yishu He, Mengting Wan, et al.
Digestive Diseases and Sciences (2024)
Closed Access
Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovations
Shi‐Yan Zhang
World Journal of Gastroenterology (2024) Vol. 30, Iss. 41, pp. 4411-4416
Closed Access
Page 1 - Next Page

Scroll to top